- Trials with a EudraCT protocol (8)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
8 result(s) found for: Glabella.
Displaying page 1 of 1.
EudraCT Number: 2013-004646-42 | Sponsor Protocol Number: 05PF1311 | Start Date*: 2014-03-17 | |||||||||||
Sponsor Name:Q-MED AB | |||||||||||||
Full Title: A randomized, evaluator-blinded, comparative study to evaluate the efficacy and safety of different injection volumes of botulinum toxin type A, Azzalure®, in the glabellar lines. | |||||||||||||
Medical condition: Glabella frown lines | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: SE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-005568-24 | Sponsor Protocol Number: 214-06/06 | Start Date*: 2007-03-29 | |||||||||||
Sponsor Name:Dermatologikum Hamburg | |||||||||||||
Full Title: Prüfung der Wirksamkeit und der Verträglichkeit von Botulinum-Toxin (Xeomin®) in verschiedenen Verdünnungen Evaluation of the Efficacy and Safety of Botulinumtoxin (Xeomin®) in different dilutions | |||||||||||||
Medical condition: Moderate to severe glabellar frown lines | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-000749-21 | Sponsor Protocol Number: 4.20 | Start Date*: 2016-03-14 |
Sponsor Name:Medizinische Hochschule Hannover | ||
Full Title: Botulinumtoxin A for emotional stabilization in borderline personality disorder | ||
Medical condition: Borderline personality disorder | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-005637-37 | Sponsor Protocol Number: ASF-1057-206 | Start Date*: 2007-02-28 |
Sponsor Name:Astion Danmark A/S | ||
Full Title: Comparative, placebo controlled, double-blind efficacy and safety study in patients with seborrhoeic dermatitis comparing a topical cream containing 2% Nicotinamide combined with either 0%, 0.5% or... | ||
Medical condition: Seborrhoeic Dermatitis. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2007-004648-54 | Sponsor Protocol Number: ASF-1057-302 | Start Date*: 2007-12-10 |
Sponsor Name:Astion Pharma A/S | ||
Full Title: Efficacy and safety of ASF-1057 cream 0.5% in the treatment of seborrhoeic dermatitis: A phase III randomised, multi-centre, double-blind, active comparator (ketoconazole cream 2%) and placebo cont... | ||
Medical condition: Seborrhoeic dermatitis. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Prematurely Ended) GB (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2020-001318-39 | Sponsor Protocol Number: UNIHHSkinQuality202000401 | Start Date*: 2021-04-30 |
Sponsor Name:Prof. Dr. Martina Kerscher, University of Hamburg | ||
Full Title: Skin perception after intradermal application of IncobotulinumtoxinA within upper and midface (Interventional Phase II) | ||
Medical condition: Skin perception after intradermal application of INCOBOTULINUMTOXIN A within upper and midface | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2007-004627-38 | Sponsor Protocol Number: ASF-1057-301 | Start Date*: 2007-11-12 |
Sponsor Name:Astion Pharma A/S | ||
Full Title: Efficacy and safety of ASF 1057 cream 0.5% in the treatment of seborrhoeic dermatitis: A phase III randomised, double-blind, vehicle- and placebo controlled, parallel groups, multi-centre trial | ||
Medical condition: Seborrhoeic dermatitis. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) DE (Completed) DK (Completed) FR (Completed) FI (Completed) GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2014-005555-80 | Sponsor Protocol Number: V00400SB302 | Start Date*: 2015-05-21 | |||||||||||
Sponsor Name:Pierre Fabre Dermatologie represented by IRPF | |||||||||||||
Full Title: Efficacy and safety of Hemangiol solution in the treatment of high risk infantile hemangioma. A Multinational Single Arm Study | |||||||||||||
Medical condition: High risk infantile haemangioma | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
